Brook, JD, McCurrach, ME, Harley, HG, Buckler, AJ, Church, D, et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3 end of a transcript encoding a protein kinase family member. Cell 1992, 68: 799–808.
Howeler, CJ, Busch, HF, Geraedts, JP, Niermeijer, MF, Staal, A. Anticipation in myotonic dystrophy: fact or fiction? Brain 1989, 112: 779–797.
Arocena, DG, Iwahashi, CK, Won, N, Beilina, A, Ludwig, AL, et al. Induction of inclusion formation and disruption of lamin A/C structure by premutation CGG‐repeat RNA in human cultured neural cells. Hum Mol Genet 2005, 14: 3661–3671.
Taneja, KL. Localization of trinucleotide repeat sequences in myotonic dystrophy cells using a single fluorochrome‐labeled PNA probe. Biotechniques 1998, 24: 472–476.
Rudnicki, DD, Holmes, SE, Lin, MW, Thornton, CA, Ross, CA, et al. Huntington`s disease—like 2 is associated with CUG repeat‐containing RNA foci. Ann Neurol 2007, 61: 272–282.
Lin, X, Ashizawa, T. SCA10 and ATTCT repeat expansion: clinical features and molecular aspects. Cytogenet Genome Res 2003, 100: 184–188.
Mankodi, A, Teng‐Umnuay, P, Krym, M, Henderson, D, Swanson, M, et al. Ribonuclear inclusions in skeletal muscle in myotonic dystrophy types 1 and 2. Ann Neurol 2003, 54: 760–768.
Daughters, RS, Tuttle, DL, Gao, W, Ikeda, Y, Moseley, ML, et al. RNA gain‐of‐function in spinocerebellar ataxia type 8. PLoS Genet 2009, 5: e1000600.
Lee, JE, Cooper, TA. Pathogenic mechanisms of myotonic dystrophy. Biochem Soc Trans 2009, 37: 1281–1286.
Li, LB, Yu, Z, Teng, X, Bonini, NM. RNA toxicity is a component of ataxin‐3 degeneration in Drosophila. Nature 2008, 453: 1107–1111.
Mutsuddi, M, Marshall, CM, Benzow, KA, Koob, MD, Rebay, I. The spinocerebellar ataxia 8 noncoding RNA causes neurodegeneration and associates with staufen in Drosophila. Curr Biol 2004, 14: 302–308.
Chen, IC, Lin, HY, Lee, GC, Kao, SH, Chen, CM, et al. Spinocerebellar ataxia type 8 larger triplet expansion alters histone modification and induces RNA foci. BMC Mol Biol 2009, 10: 9.
Sato, N, Amino, T, Kobayashi, K, Asakawa, S, Ishiguro, T, et al. Spinocerebellar ataxia type 31 is associated with “inserted” penta‐nucleotide repeats containing (TGGAA)n. Am J Hum Genet 2009, 85: 544–557.
Handa, V, Goldwater, D, Stiles, D, Cam, M, Poy, G, et al. Long CGG‐repeat tracts are toxic to human cells: implications for carriers of Fragile X premutation alleles. FEBS Lett 2005, 579: 2702–2708.
Iwahashi, CK, Yasui, DH, An, HJ, Greco, CM, Tassone, F, et al. Protein composition of the intranuclear inclusions of FXTAS. Brain 2006, 129: 256–271.
Hashem, V, Galloway, JN, Mori, M, Willemsen, R, Oostra, BA, et al. Ectopic expression of CGG containing mRNA is neurotoxic in mammals. Hum Mol Genet 2009, 18: 2443–2451.
Roze, E, Saudou, F, Caboche, J. Pathophysiology of Huntington`s disease: from huntingtin functions to potential treatments. Curr Opin Neurol 2008, 21: 497–503.
Koide, R, Ikeuchi, T, Onodera, O, Tanaka, H, Igarashi, S, et al. Unstable expansion of CAG repeat in hereditary dentatorubral‐pallidoluysian atrophy (DRPLA). Nat Genet 1994, 6: 9–13.
Sanpei, K, Takano, H, Igarashi, S, Sato, T, Oyake, M, et al. Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT. Nat Genet 1996, 14: 277–284.
Yu, Z, Wang, AM, Robins, DM, Lieberman, AP. Altered RNA splicing contributes to skeletal muscle pathology in Kennedy disease knock‐in mice. Dis Model Mech 2009, 2: 500–507.
Zhuchenko, O, Bailey, J, Bonnen, P, Ashizawa, T, Stockton, DW, et al. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A‐voltage‐dependent calcium channel. Nat Genet 1997, 15: 62–69.
Garden, GA, La Spada, AR. Molecular pathogenesis and cellular pathology of spinocerebellar ataxia type 7 neurodegeneration. Cerebellum 2008, 7: 138–149.
Holmes, SE, O`Hearn, E, Margolis, RL. Why is SCA12 different from other SCAs? Cytogenet Genome Res 2003, 100: 189–197.
Stevanin, G, Brice, A. Spinocerebellar ataxia 17 (SCA17) and Huntington`s disease‐like 4 (HDL4). Cerebellum 2008, 7: 170–178.
Bauer, PO, Nukina, N. The pathogenic mechanisms of polyglutamine diseases and current therapeutic strategies. J Neurochem 2009, 110: 1737–1765.
Taneja, KL, McCurrach, M, Schalling, M, Housman, D, Singer, RH. Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues. J Cell Biol 1995, 128: 995–1002.
Liquori, CL, Ricker, K, Moseley, ML, Jacobsen, JF, Kress, W, et al. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 2001, 293: 864–867.
Napierala, M, Krzyzosiak, WJ. CUG repeats present in myotonin kinase RNA form metastable “slippery” hairpins. J Biol Chem 1997, 272: 31079–31085.
Sobczak, K, Krzyzosiak, WJ. CAG repeats containing CAA interruptions form branched hairpin structures in spinocerebellar ataxia type 2 transcripts. J Biol Chem 2005, 280: 3898–3910.
Napierala, M, Michalowski, D, de Mezer, M, Krzyzosiak, WJ. Facile FMR1 mRNA structure regulation by interruptions in CGG repeats. Nucleic Acids Res 2005, 33: 451–463.
Miller, JW, Urbinati, CR, Teng‐Umnuay, P, Stenberg, MG, Byrne, BJ, et al. Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. Embo J 2000, 19: 4439–4448.
Yuan, Y, Compton, SA, Sobczak, K, Stenberg, MG, Thornton, CA, et al. Muscleblind‐like 1 interacts with RNA hairpins in splicing target and pathogenic RNAs. Nucleic Acids Res 2007, 35: 5474–5486.
Kanadia, RN, Johnstone, KA, Mankodi, A, Lungu, C, Thornton, CA, et al. A muscleblind knockout model for myotonic dystrophy. Science 2003, 302: 1978–1980.
Kanadia, RN, Shin, J, Yuan, Y, Beattie, SG, Wheeler, TM, et al. Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy. Proc Natl Acad Sci U S A 2006, 103: 11748–11753.
Ho, TH, Savkur, RS, Poulos, MG, Mancini, MA, Swanson, MS, et al. Colocalization of muscleblind with RNA foci is separable from mis‐regulation of alternative splicing in myotonic dystrophy. J Cell Sci 2005, 118: 2923–2933.
Pascual, M, Vicente, M, Monferrer, L, Artero, R. The Muscleblind family of proteins: an emerging class of regulators of developmentally programmed alternative splicing. Differentiation 2006, 74: 65–80.
Jiang, H, Mankodi, A, Swanson, MS, Moxley, RT, Thornton, CA. Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons. Hum Mol Genet 2004, 13: 3079–3088.
Charlet, BN, Savkur, RS, Singh, G, Philips, AV, Grice, EA, et al. Loss of the muscle‐specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. Mol Cell 2002, 10: 45–53.
Kino, Y, Washizu, C, Oma, Y, Onishi, H, Nezu, Y, et al. MBNL and CELF proteins regulate alternative splicing of the skeletal muscle chloride channel CLCN1. Nucleic Acids Res 2009, 37: 6477–6490.
Dansithong, W, Paul, S, Comai, L, Reddy, S. MBNL1 is the primary determinant of focus formation and aberrant insulin receptor splicing in DM1. J Biol Chem 2005, 280: 5773–5780.
Savkur, RS, Philips, AV, Cooper, TA, Dalton, JC, Moseley, ML, et al. Insulin receptor splicing alteration in myotonic dystrophy type 2. Am J Hum Genet 2004, 74: 1309–1313.
Ho, TH, Charlet, BN, Poulos, MG, Singh, G, Swanson, MS, et al. Muscleblind proteins regulate alternative splicing. Embo J 2004, 23: 3103–3112.
Leroy, O, Dhaenens, CM, Schraen‐Maschke, S, Belarbi, K, Delacourte, A, et al. ETR‐3 represses Tau exons 2/3 inclusion, a splicing event abnormally enhanced in myotonic dystrophy type I. J Neurosci Res 2006, 84: 852–859.
Lin, X, Miller, JW, Mankodi, A, Kanadia, RN, Yuan, Y, et al. Failure of MBNL1‐dependent post‐natal splicing transitions in myotonic dystrophy. Hum Mol Genet 2006, 15: 2087–2097.
Ho, TH, Bundman, D, Armstrong, DL, Cooper, TA. Transgenic mice expressing CUG‐BP1 reproduce splicing mis‐regulation observed in myotonic dystrophy. Hum Mol Genet 2005, 14: 1539–1547.
Buj‐Bello, A, Furling, D, Tronchere, H, Laporte, J, Lerouge, T, et al. Muscle‐specific alternative splicing of myotubularin‐related 1 gene is impaired in DM1 muscle cells. Hum Mol Genet 2002, 11: 2297–2307.
Kimura, T, Nakamori, M, Lueck, JD, Pouliquin, P, Aoike, F, et al. Altered mRNA splicing of the skeletal muscle ryanodine receptor and sarcoplasmic/endoplasmic reticulum Ca2+‐ATPase in myotonic dystrophy type 1. Hum Mol Genet 2005, 14: 2189–2200.
Hino, S, Kondo, S, Sekiya, H, Saito, A, Kanemoto, S, et al. Molecular mechanisms responsible for aberrant splicing of SERCA1 in myotonic dystrophy type 1. Hum Mol Genet 2007, 16: 2834–2843.
Wang, GS, Kearney, DL, De Biasi, M, Taffet, G, Cooper, TA. Elevation of RNA‐binding protein CUGBP1 is an early event in an inducible heart‐specific mouse model of myotonic dystrophy. J Clin Invest 2007, 117: 2802–2811.
Philips, AV, Timchenko, LT, Cooper, TA. Disruption of splicing regulated by a CUG‐binding protein in myotonic dystrophy. Science 1998, 280: 737–741.
Warf, MB, Berglund, JA. MBNL binds similar RNA structures in the CUG repeats of myotonic dystrophy and its pre‐mRNA substrate cardiac troponin T. RNA 2007, 13: 2238–2251.
Salvatori, S, Furlan, S, Fanin, M, Picard, A, Pastorello, E, et al. Comparative transcriptional and biochemical studies in muscle of myotonic dystrophies (DM1 and DM2). Neurol Sci 2009, 30: 185–192.
Vihola, A, Bachinski, LL, Sirito, M, Olufemi, SE, Hajibashi, S, et al. Differences in aberrant expression and splicing of sarcomeric proteins in the myotonic dystrophies DM1 and DM2 Acta Neuropathol 2010, 119: 465–479.
Timchenko, LT, Miller, JW, Timchenko, NA, DeVore, DR, Datar, KV, et al. Identification of a (CUG)n triplet repeat RNA‐binding protein and its expression in myotonic dystrophy. Nucleic Acids Res 1996, 24: 4407–4414.
Kim, DH, Langlois, MA, Lee, KB, Riggs, AD, Puymirat, J, et al. HnRNP H inhibits nuclear export of mRNA containing expanded CUG repeats and a distal branch point sequence. Nucleic Acids Res 2005, 33: 3866–3874.
Fardaei, M, Larkin, K, Brook, JD, Hamshere, MG. In vivo co‐localisation of MBNL protein with DMPK expanded‐repeat transcripts. Nucleic Acids Res 2001, 29: 2766–2771.
Sofola, OA, Jin, P, Qin, Y, Duan, R, Liu, H, et al. RNA‐binding proteins hnRNP A2/B1 and CUGBP1 suppress fragile X CGG premutation repeat‐induced neurodegeneration in a Drosophila model of FXTAS. Neuron 2007, 55: 565–571.
Jin, P, Duan, R, Qurashi, A, Qin, Y, Tian, D, et al. Pur alpha binds to rCGG repeats and modulates repeat‐mediated neurodegeneration in a Drosophila model of fragile X tremor/ataxia syndrome. Neuron 2007, 55: 556–564.
Ebralidze, A, Wang, Y, Petkova, V, Ebralidse, K, Junghans, RP. RNA leaching of transcription factors disrupts transcription in myotonic dystrophy. Science 2004, 303: 383–387.
Salisbury, E, Schoser, B, Schneider‐Gold, C, Wang, GL, Huichalaf, C, et al. Expression of RNA CCUG repeats dysregulates translation and degradation of proteins in myotonic dystrophy 2 patients. Am J Pathol 2009, 175: 748–762.
Chai, Y, Koppenhafer, SL, Shoesmith, SJ, Perez, MK, Paulson, HL. Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro. Hum Mol Genet 1999, 8: 673–682.
Peel, AL, Rao, RV, Cottrell, BA, Hayden, MR, Ellerby, LM, et al. Double‐stranded RNA‐dependent protein kinase, PKR, binds preferentially to Huntington`s disease (HD) transcripts and is activated in HD tissue. Hum Mol Genet 2001, 10: 1531–1538.
Tian, B, White, RJ, Xia, T, Welle, S, Turner, DH, et al. Expanded CUG repeat RNAs form hairpins that activate the double‐stranded RNA‐dependent protein kinase PKR. RNA 2000, 6: 79–87.
Malinina, L. Possible involvement of the RNAi pathway in trinucleotide repeat expansion diseases. J Biomol Struct Dyn 2005, 23: 233–235.
Krol, J, Fiszer, A, Mykowska, A, Sobczak, K, de Mezer, M, et al. Ribonuclease dicer cleaves triplet repeat hairpins into shorter repeats that silence specific targets. Mol Cell 2007, 25: 575–586.
Osborne, RJ, Lin, X, Welle, S, Sobczak, K, O`Rourke, JR, et al. Transcriptional and post‐transcriptional impact of toxic RNA in myotonic dystrophy. Hum Mol Genet 2009, 18: 1471–1481.
Risheg, H, Graham, JM Jr, Clark, RD, Rogers, RC, Opitz, JM, et al. A recurrent mutation in MED12 leading to R961W causes Opitz‐Kaveggia syndrome. Nat Genet 2007, 39: 451–453.
Kumari, D, Usdin, K. Chromatin remodeling in the noncoding repeat expansion diseases. J Biol Chem 2009, 284: 7413–7417.
Alwazzan, M, Newman, E, Hamshere, MG, Brook, JD. Myotonic dystrophy is associated with a reduced level of RNA from the DMWD allele adjacent to the expanded repeat. Hum Mol Genet 1999, 8: 1491–1497.
Gennarelli, M, Pavoni, M, Amicucci, P, Angelini, C, Menegazzo, E, et al. Reduction of the DM‐associated homeo domain protein (DMAHP) mRNA in different brain areas of myotonic dystrophy patients. Neuromuscul Disord 1999, 9: 215–219.
Frisch, R, Singleton, KR, Moses, PA, Gonzalez, IL, Carango, P, et al. Effect of triplet repeat expansion on chromatin structure and expression of DMPK and neighboring genes, SIX5 and DMWD, in myotonic dystrophy. Mol Genet Metab 2001, 74: 281–291.
Kuyumcu‐Martinez, NM, Wang, GS, Cooper, TA. Increased steady‐state levels of CUGBP1 in myotonic dystrophy 1 are due to PKC‐mediated hyperphosphorylation. Mol Cell 2007, 28: 68–78.
Wang, GS, Kuyumcu‐Martinez, MN, Sarma, S, Mathur, N, Wehrens, XH, et al. PKC inhibition ameliorates the cardiac phenotype in a mouse model of myotonic dystrophy type 1. J Clin Invest 2009, 119: 3797–3806.
Hernandez‐Hernandez, O, Bermudez‐de‐Leon, M, Gomez, P, Velazquez‐Bernardino, P, Garcia‐Sierra, F, et al. Myotonic dystrophy expanded CUG repeats disturb the expression and phosphorylation of tau in PC12 cells. J Neurosci Res 2006, 84: 841–851.
Salisbury, E, Sakai, K, Schoser, B, Huichalaf, C, Schneider‐Gold, C, et al. Ectopic expression of cyclin D3 corrects differentiation of DM1 myoblasts through activation of RNA CUG‐binding protein, CUGBP1. Exp Cell Res 2008, 314: 2266–2278.
Timchenko, NA, Cai, ZJ, Welm, AL, Reddy, S, Ashizawa, T, et al. RNA CUG repeats sequester CUGBP1 and alter protein levels and activity of CUGBP1. J Biol Chem 2001, 276: 7820–7826.
Pelletier, R, Hamel, F, Beaulieu, D, Patry, L, Haineault, C, et al. Absence of a differentiation defect in muscle satellite cells from DM2 patients. Neurobiol Dis 2009, 36: 181–190.
Ranum, LP, Cooper, TA. RNA‐mediated neuromuscular disorders. Annu Rev Neurosci 2006, 29: 259–277.
Du, H, Cline, MS, Osborne, RJ, Tuttle, DL, Clark, TA, et al. Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy Nat Struct Mol Biol 2010, 17: 187–193.
Paillard, L, Omilli, F, Legagneux, V, Bassez, T, Maniey, D, et al. EDEN and EDEN‐BP, a cis element and an associated factor that mediate sequence‐specific mRNA deadenylation in Xenopus embryos. Embo J 1998, 17: 278–287.
Moraes, KC, Wilusz, CJ, Wilusz, J. CUG‐BP binds to RNA substrates and recruits PARN deadenylase. RNA 2006, 12: 1084–1091.
Vlasova, IA, Tahoe, NM, Fan, D, Larsson, O, Rattenbacher, B, et al. Conserved GU‐rich elements mediate mRNA decay by binding to CUG‐binding protein 1. Mol Cell 2008, 29: 263–270.
Zhang, L, Lee, JE, Wilusz, J, Wilusz, CJ. The RNA‐binding protein CUGBP1 regulates stability of tumor necrosis factor mRNA in muscle cells: implications for myotonic dystrophy. J Biol Chem 2008, 283: 22457–22463.
Mammarella, A, Ferroni, P, Paradiso, M, Martini, F, Paoletti, V, et al. Tumor necrosis factor‐alpha and myocardial function in patients with myotonic dystrophy type 1. J Neurol Sci 2002, 201: 59–64.
Iakova, P, Wang, GL, Timchenko, L, Michalak, M, Pereira‐Smith, OM, et al. Competition of CUGBP1 and calreticulin for the regulation of p21 translation determines cell fate. Embo J 2004, 23: 406–417.
Timchenko, NA, Welm, AL, Lu, X, Timchenko, LT. CUG repeat binding protein (CUGBP1) interacts with the 5′ region of C/EBPbeta mRNA and regulates translation of C/EBPbeta isoforms. Nucleic Acids Res 1999, 27: 4517–4525.
Timchenko, NA, Patel, R, Iakova, P, Cai, ZJ, Quan, L, et al. Overexpression of CUG triplet repeat‐binding protein, CUGBP1, in mice inhibits myogenesis. J Biol Chem 2004, 279: 13129–13139.
Helbling‐Leclerc, A, Zhang, X, Topaloglu, H, Cruaud, C, Tesson, F, et al. et al. Mutations in the laminin alpha 2‐chain gene (LAMA2) cause merosin‐deficient congenital muscular dystrophy. Nat Genet 1995, 11: 216–218.
Camacho Vanegas, O, Bertini, E, Zhang, RZ, Petrini, S, Minosse, C, et al. Ullrich scleroatonic muscular dystrophy is caused by recessive mutations in collagen type VI. Proc Natl Acad Sci U S A 2001, 98: 7516–7521.
Matsumura, K, Tome, FM, Collin, H, Azibi, K, Chaouch, M, et al. Deficiency of the 50K dystrophin‐associated glycoprotein in severe childhood autosomal recessive muscular dystrophy. Nature 1992, 359: 320–322.
Kanagawa, M, Toda, T. The genetic and molecular basis of muscular dystrophy: roles of cell‐matrix linkage in the pathogenesis. J Hum Genet 2006, 51: 915–926.
Botta, A, Rinaldi, F, Catalli, C, Vergani, L, Bonifazi, E, et al. The CTG repeat expansion size correlates with the splicing defects observed in muscles from myotonic dystrophy type 1 patients. J Med Genet 2008, 45: 639–646.
Jasinska, A, Michlewski, G, de Mezer, M, Sobczak, K, Kozlowski, P, et al. Structures of trinucleotide repeats in human transcripts and their functional implications. Nucleic Acids Res 2003, 31: 5463–5468.
Ditch, S, Sammarco, MC, Banerjee, A, Grabczyk, E. Progressive GAA.TTC repeat expansion in human cell lines. PLoS Genet 2009, 5: e1000704.
Gomes‐Pereira, M, Fortune, MT, Ingram, L, McAbney, JP, Monckton, DG. Pms2 is a genetic enhancer of trinucleotide CAG.CTG repeat somatic mosaicism: implications for the mechanism of triplet repeat expansion.Hum Mol Genet 2004, 13: 1815–1825.
Matsuura, T, Yamagata, T, Burgess, DL, Rasmussen, A, Grewal, RP, et al. Large expansion of the ATTCT pentanucleotide repeat in spinocerebellar ataxia type 10. Nat Genet 2000, 26: 191–194.
Handa, V, Yeh, HJ, McPhie, P, Usdin, K. The AUUCU repeats responsible for spinocerebellar ataxia type 10 form unusual RNA hairpins. J Biol Chem 2005, 280: 29340–29345.
Lin, X, Ashizawa, T. Recent progress in spinocerebellar ataxia type‐10 (SCA10). Cerebellum 2005, 4: 37–42.
Sobczak, K, Krzyzosiak, WJ. Patterns of CAG repeat interruptions in SCA1 and SCA2 genes in relation to repeat instability. Hum Mutat 2004, 24: 236–247.
Sobczak, K, Krzyzosiak, WJ. Imperfect CAG repeats form diverse structures in SCA1 transcripts. J Biol Chem 2004, 279: 41563–41572.
Margolis, JM, Schoser, BG, Moseley, ML, Day, JW, Ranum, LP. DM2 intronic expansions: evidence for CCUG accumulation without flanking sequence or effects on ZNF9 mRNA processing or protein expression. Hum Mol Genet 2006, 15: 1808–1815.
Wakamiya, M, Matsuura, T, Liu, Y, Schuster, GC, Gao, R, et al. The role of ataxin 10 in the pathogenesis of spinocerebellar ataxia type 10. Neurology 2006, 67: 607–613.
Bidichandani, SI, Ashizawa, T, Patel, PI. The GAA triplet‐repeat expansion in Friedreich ataxia interferes with transcription and may be associated with an unusual DNA structure. Am J Hum Genet 1998, 62: 111–121.
Tassone, F, Hagerman, RJ, Taylor, AK, Gane, LW, Godfrey, TE, et al. Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile‐X syndrome. Am J Hum Genet 2000, 66: 6–15.
Oberle, I, Rousseau, F, Heitz, D, Kretz, C, Devys, D, et al. Instability of a 550‐base pair DNA segment and abnormal methylation in fragile X syndrome. Science 1991, 252: 1097–1102.
Holt, I, Mittal, S, Furling, D, Butler‐Browne, GS, Brook, JD, et al. Defective mRNA in myotonic dystrophy accumulates at the periphery of nuclear splicing speckles. Genes Cells 2007, 12: 1035–1048.
Orengo, JP, Chambon, P, Metzger, D, Mosier, DR, Snipes, GJ, et al. Expanded CTG repeats within the DMPK 3′ UTR causes severe skeletal muscle wasting in an inducible mouse model for myotonic dystrophy. Proc Natl Acad Sci U S A 2008, 105: 2646–2651.
Mankodi, A, Logigian, E, Callahan, L, McClain, C, White, R, et al. Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science 2000, 289: 1769–1773.
Mahadevan, MS, Yadava, RS, Yu, Q, Balijepalli, S, Frenzel‐McCardell, CD, et al. Reversible model of RNA toxicity and cardiac conduction defects in myotonic dystrophy. Nat Genet 2006, 38: 1066–1070.
Michlewski, G, Krzyzosiak, WJ. Pathogenesis of spinocerebellar ataxias viewed from the RNA perspective. Cerebellum 2005, 4: 19–24.
Botta, A, Caldarola, S, Vallo, L, Bonifazi, E, Fruci, D, et al. Effect of the [CCTG]n repeat expansion on ZNF9 expression in myotonic dystrophy type II (DM2). Biochim Biophys Acta 2006, 1762: 329–334.
Mastroyiannopoulos, NP, Feldman, ML, Uney, JB, Mahadevan, MS, Phylactou, LA. Woodchuck post‐transcriptional element induces nuclear export of myotonic dystrophy 3′ untranslated region transcripts. EMBO Rep 2005, 6: 458–463.
Dansithong, W, Wolf, CM, Sarkar, P, Paul, S, Chiang, A, et al. Cytoplasmic CUG RNA foci are insufficient to elicit key DM1 features. PLoS ONE 2008, 3: e3968.
Mastroyiannopoulos, NP, Chrysanthou, E, Kyriakides, TC, Uney, JB, Mahadevan, MS, et al. The effect of myotonic dystrophy transcript levels and location on muscle differentiation. Biochem Biophys Res Commun 2008, 377: 526–531.
Garcia‐Lopez, A, Monferrer, L, Garcia‐Alcover, I, Vicente‐Crespo, M, Alvarez‐Abril, MC, et al. Genetic and chemical modifiers of a CUG toxicity model in Drosophila. PLoS ONE 2008, 3: e1595.
Mulders, SA, van den Broek, WJ, Wheeler, TM, Croes, HJ, van Kuik‐Romeijn, P, et al. Triplet‐repeat oligonucleotide‐mediated reversal of RNA toxicity in myotonic dystrophy. Proc Natl Acad Sci U S A 2009, 106: 13915–13920.
Furling, D, Doucet, G, Langlois, MA, Timchenko, L, Belanger, E, et al. Viral vector producing antisense RNA restores myotonic dystrophy myoblast functions. Gene Ther 2003, 10: 795–802.
Miller, VM, Xia, H, Marrs, GL, Gouvion, CM, Lee, G, et al. Allele‐specific silencing of dominant disease genes. Proc Natl Acad Sci U S A 2003, 100: 7195–7200.
Langlois, MA, Lee, NS, Rossi, JJ, Puymirat, J. Hammerhead ribozyme‐mediated destruction of nuclear foci in myotonic dystrophy myoblasts. Mol Ther 2003, 7: 670–680.
Harper, SQ, Staber, PD, He, X, Eliason, SL, Martins, IH, et al. RNA interference improves motor and neuropathological abnormalities in a Huntington`s disease mouse model. Proc Natl Acad Sci U S A 2005, 102: 5820–5825.
Scholefield, J, Greenberg, LJ, Weinberg, MS, Arbuthnot, PB, Abdelgany, A, et al. Design of RNAi hairpins for mutation‐specific silencing of ataxin‐7 and correction of a SCA7 phenotype. PLoS ONE 2009, 4: e7232.
Yen, L, Strittmatter, SM, Kalb, RG. Sequence‐specific cleavage of Huntingtin mRNA by catalytic DNA. Ann Neurol 1999, 46: 366–373.
Wheeler, TM, Sobczak, K, Lueck, JD, Osborne, RJ, Lin, X, et al. Reversal of RNA dominance by displacement of protein sequestered on triplet repeat RNA. Science 2009, 325: 336–339.
Warf, MB, Nakamori, M, Matthys, CM, Thornton, CA, Berglund, JA. Pentamidine reverses the splicing defects associated with myotonic dystrophy. Proc Natl Acad Sci U S A 2009, 106: 18551–18556.
Arambula, JF, Ramisetty, SR, Baranger, AM, Zimmerman, SC. A simple ligand that selectively targets CUG trinucleotide repeats and inhibits MBNL protein binding. Proc Natl Acad Sci U S A 2009, 106: 16068–16073.
Pushechnikov, A, Lee, MM, Childs‐Disney, JL, Sobczak, K, French, JM, et al. Rational design of ligands targeting triplet repeating transcripts that cause RNA dominant disease: application to myotonic muscular dystrophy type 1 and spinocerebellar ataxia type 3. J Am Chem Soc 2009, 131: 9767–9779.
Gareiss, PC, Sobczak, K, McNaughton, BR, Palde, PB, Thornton, CA, et al. Dynamic combinatorial selection of molecules capable of inhibiting the (CUG) repeat RNA‐MBNL1 interaction in vitro: discovery of lead compounds targeting myotonic dystrophy (DM1). J Am Chem Soc 2008, 130: 16254–16261.
de Haro, M, Al‐Ramahi, I, De Gouyon, B, Ukani, L, Rosa, A, et al. MBNL1 and CUGBP1 modify expanded CUG‐induced toxicity in a Drosophila model of myotonic dystrophy type 1. Hum Mol Genet 2006, 15: 2138–2145.
Wheeler, TM, Lueck, JD, Swanson, MS, Dirksen, RT, Thornton, CA. Correction of ClC‐1 splicing eliminates chloride channelopathy and myotonia in mouse models of myotonic dystrophy. J Clin Invest 2007, 117: 3952–3957.
Corbeil‐Girard, LP, Klein, AF, Sasseville, AM, Lavoie, H, Dicaire, MJ, et al. PABPN1 overexpression leads to upregulation of genes encoding nuclear proteins that are sequestered in oculopharyngeal muscular dystrophy nuclear inclusions. Neurobiol Dis 2005, 18: 551–567.
Jung, J, Xu, K, Lessing, D, Bonini, NM. Preventing Ataxin‐3 protein cleavage mitigates degeneration in a Drosophila model of SCA3. Hum Mol Genet 2009, 18: 4843–4852.
Branco, J, Al‐Ramahi, I, Ukani, L, Perez, AM, Fernandez‐Funez, P, et al. Comparative analysis of genetic modifiers in Drosophila points to common and distinct mechanisms of pathogenesis among polyglutamine diseases. Hum Mol Genet 2008, 17: 376–390.